Related Experiment Videos
[Hyperlipoproteinemias in childhood]
1Mautner Markhof'schen Kinderspital der Stadt Wien.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1994
Summary
Diagnosing and treating childhood hypercholesterolemia is crucial for preventing adult coronary heart disease. Early intervention, including dietary changes, is recommended for children at risk, but general neonatal screening is not advised.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Risk Factors
- Metabolic Disorders
Context:
- Hyperlipidemic states, particularly hypercholesterolemia, are increasingly recognized as significant health concerns in childhood.
- Elevated cholesterol levels in children are linked to increased risk of coronary vascular disease later in life.
- Current diagnostic standards for pediatric hyperlipidemias often rely on data transferred from adult studies.
Purpose:
- To outline the importance of diagnosing and treating hypercholesterolemia in children.
- To emphasize the rationale behind early intervention for pediatric lipid disorders.
- To provide guidance on the classification and management of hyperlipidemias in the pediatric age group.
Summary:
- Hypercholesterolemia should be diagnosed in children over 2 years old, with familial hypercholesterolemia being the most common genetic disorder.
- Treatment involves dietary modifications, such as reduced saturated fats and soy protein substitution.
- Children with a family history of cardiovascular disease or hyperlipidemia should be referred to specialized metabolic clinics.
Impact:
- Early diagnosis and treatment of childhood hypercholesterolemia can mitigate long-term cardiovascular risks.
- Implementing dietary interventions can effectively lower cholesterol levels in affected children.
- This approach supports proactive management of lipid disorders from a young age, potentially reducing the burden of adult cardiovascular disease.